SEC Form 4 · accession 0000878526-18-000142
NATUS MEDICAL INC · BABY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Kennedy
Officer — President and CEO · Director
Period of report
Aug 24, 2018
Accepted (ET)
Aug 29, 2018 · 1:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000878526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per shareF1 | Aug 24, 2018 | A | 22,695 | $35.25 | A | 130,283 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock OptionF2 | $35.25 | Aug 24, 2018 | A | 74,124 | A | Jul 11, 2019 | Jul 11, 2024 | Common Stock | 74,124 | 74,124 | D |
Explanation of responses
- F1Performance Restricted Stock will be eligible to vest after 2.5 years and based upon performance goals set forth.
- F2Stock Options vest over 4 years from the date of the grant. 25% will vest on the first anniversary of the grant, 25% on the second anniversary of the grant, 25% on the third anniversary of the grant, and 25% on the fourth anniversary of the grant.